Clinical Trials Using Monoclonal Antibody MGA271

Clinical trials are research studies that involve people. The clinical trials on this list are studying Monoclonal Antibody MGA271. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Enoblituzumab in Treating Patients with Localized, Intermediate, or High-Risk Prostate Cancer

    This pilot phase II trial studies the side effects of enoblituzumab in treating patients with localized, intermediate, or high-risk prostate cancer. Immunotherapy with enoblituzumab, may induce changes in body’s immune system and may interfere with the ability of tumor cells to grow and spread.
    Location: Johns Hopkins University / Sidney Kimmel Cancer Center, Baltimore, Maryland